Oruka Therapeutics Stock Forward View
| ORKA Stock | 34.23 1.03 2.92% |
Oruka Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Oruka Therapeutics stock prices and determine the direction of Oruka Therapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Oruka Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, The RSI of Oruka Therapeutics' share price is at 58. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Oruka Therapeutics, making its price go up or down. Momentum 58
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.59) | EPS Estimate Current Year (2.06) | EPS Estimate Next Year (2.39) | Wall Street Target Price 55.6667 | EPS Estimate Current Quarter (0.53) |
Using Oruka Therapeutics hype-based prediction, you can estimate the value of Oruka Therapeutics from the perspective of Oruka Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Oruka Therapeutics using Oruka Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Oruka using crowd psychology based on the activity and movement of Oruka Therapeutics' stock price.
Oruka Therapeutics Implied Volatility | 1.55 |
Oruka Therapeutics' implied volatility exposes the market's sentiment of Oruka Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Oruka Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Oruka Therapeutics stock will not fluctuate a lot when Oruka Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Oruka Therapeutics on the next trading day is expected to be 33.61 with a mean absolute deviation of 1.04 and the sum of the absolute errors of 63.31. Oruka Therapeutics after-hype prediction price | USD 33.35 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Oruka Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Oruka contract
Based on the Rule 16, the options market is currently suggesting that Oruka Therapeutics will have an average daily up or down price movement of about 0.0969% per day over the life of the 2026-03-20 option contract. With Oruka Therapeutics trading at USD 34.23, that is roughly USD 0.0332 . If you think that the market is fully incorporating Oruka Therapeutics' daily price movement you should consider acquiring Oruka Therapeutics options at the current volatility level of 1.55%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Oruka Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Oruka Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Oruka Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Oruka Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Oruka Therapeutics' open interest, investors have to compare it to Oruka Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Oruka Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Oruka. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Oruka Therapeutics Additional Predictive Modules
Most predictive techniques to examine Oruka price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oruka using various technical indicators. When you analyze Oruka charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Oruka Therapeutics Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Oruka Therapeutics' financial statements to predict how it will affect future prices.
Cash | First Reported 2017-03-31 | Previous Quarter 65.4 M | Current Value 91.3 M | Quarterly Volatility 68.2 M |
Oruka Therapeutics Naive Prediction Price Forecast For the 3rd of February
Given 90 days horizon, the Naive Prediction forecasted value of Oruka Therapeutics on the next trading day is expected to be 33.61 with a mean absolute deviation of 1.04, mean absolute percentage error of 1.86, and the sum of the absolute errors of 63.31.Please note that although there have been many attempts to predict Oruka Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Oruka Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Oruka Therapeutics Stock Forecast Pattern
| Backtest Oruka Therapeutics | Oruka Therapeutics Price Prediction | Research Analysis |
Oruka Therapeutics Forecasted Value
In the context of forecasting Oruka Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Oruka Therapeutics' downside and upside margins for the forecasting period are 29.73 and 37.50, respectively. We have considered Oruka Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Oruka Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Oruka Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.7322 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.0379 |
| MAPE | Mean absolute percentage error | 0.0352 |
| SAE | Sum of the absolute errors | 63.3139 |
Predictive Modules for Oruka Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oruka Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Oruka Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Oruka Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oruka Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Oruka Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Oruka Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Oruka Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oruka Therapeutics' historical news coverage. Oruka Therapeutics' after-hype downside and upside margins for the prediction period are 29.47 and 37.23, respectively. We have considered Oruka Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Oruka Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Oruka Therapeutics is based on 3 months time horizon.
Oruka Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Oruka Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oruka Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oruka Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.43 | 3.88 | 0.88 | 0.09 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
34.23 | 33.35 | 2.57 |
|
Oruka Therapeutics Hype Timeline
Oruka Therapeutics is now traded for 34.23. The entity has historical hype elasticity of -0.88, and average elasticity to hype of competition of -0.09. Oruka is forecasted to decline in value after the next headline, with the price expected to drop to 33.35. The average volatility of media hype impact on the company price is about 190.2%. The price decrease on the next news is expected to be -2.57%, whereas the daily expected return is now at 0.43%. The volatility of related hype on Oruka Therapeutics is about 1813.08%, with the expected price after the next announcement by competition of 34.14. About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.59. Oruka Therapeutics last dividend was issued on the 28th of August 2024. The entity had 1:12 split on the 3rd of September 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Historical Fundamental Analysis of Oruka Therapeutics to cross-verify your projections.Oruka Therapeutics Related Hype Analysis
Having access to credible news sources related to Oruka Therapeutics' direct competition is more important than ever and may enhance your ability to predict Oruka Therapeutics' future price movements. Getting to know how Oruka Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oruka Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PHAT | Phathom Pharmaceuticals | (0.30) | 10 per month | 3.65 | 0 | 5.99 | (4.86) | 24.16 | |
| BBOT | BridgeBio Oncology Therapeutics | (0.72) | 8 per month | 3.50 | 0.02 | 8.45 | (6.24) | 27.79 | |
| RAPP | Rapport Therapeutics Common | 1.05 | 9 per month | 3.72 | 0.01 | 6.16 | (6.76) | 16.72 | |
| KOD | Kodiak Sciences | (0.13) | 10 per month | 4.44 | 0.07 | 10.04 | (6.94) | 25.07 | |
| XNCR | Xencor Inc | 0.48 | 8 per month | 0.00 | (0.07) | 6.33 | (5.08) | 16.84 | |
| NRIX | Nurix Therapeutics | (0.75) | 9 per month | 3.06 | 0.12 | 9.23 | (5.37) | 27.63 | |
| ANAB | AnaptysBio | (1.31) | 9 per month | 3.61 | 0.12 | 6.11 | (5.26) | 20.41 | |
| URGN | UroGen Pharma | 0.58 | 10 per month | 4.05 | (0.01) | 6.25 | (5.50) | 36.24 | |
| OCS | Oculis Holding AG | (1.23) | 9 per month | 1.92 | 0.15 | 5.79 | (4.03) | 15.08 | |
| MNMD | Mind Medicine | 0.19 | 8 per month | 3.40 | 0.09 | 6.21 | (4.21) | 28.06 |
Other Forecasting Options for Oruka Therapeutics
For every potential investor in Oruka, whether a beginner or expert, Oruka Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oruka Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oruka. Basic forecasting techniques help filter out the noise by identifying Oruka Therapeutics' price trends.Oruka Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oruka Therapeutics stock to make a market-neutral strategy. Peer analysis of Oruka Therapeutics could also be used in its relative valuation, which is a method of valuing Oruka Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Oruka Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Oruka Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oruka Therapeutics shares will generate the highest return on investment. By undertsting and applying Oruka Therapeutics stock market strength indicators, traders can identify Oruka Therapeutics entry and exit signals to maximize returns.
Oruka Therapeutics Risk Indicators
The analysis of Oruka Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oruka Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oruka stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.88 | |||
| Semi Deviation | 3.38 | |||
| Standard Deviation | 3.92 | |||
| Variance | 15.33 | |||
| Downside Variance | 13.46 | |||
| Semi Variance | 11.43 | |||
| Expected Short fall | (3.10) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Oruka Therapeutics
The number of cover stories for Oruka Therapeutics depends on current market conditions and Oruka Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oruka Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oruka Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Oruka Therapeutics Short Properties
Oruka Therapeutics' future price predictability will typically decrease when Oruka Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oruka Therapeutics often depends not only on the future outlook of the potential Oruka Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oruka Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.8 M | |
| Cash And Short Term Investments | 375.6 M |
Check out Historical Fundamental Analysis of Oruka Therapeutics to cross-verify your projections. For information on how to trade Oruka Stock refer to our How to Trade Oruka Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oruka Therapeutics. Anticipated expansion of Oruka directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Oruka Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Oruka Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Oruka Therapeutics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Oruka Therapeutics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Oruka Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oruka Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Oruka Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.